Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Hologic Inc (HOLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013589
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through a network of direct sales and service forces and through independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Hologic Inc, Medical Devices Deals, 2011 to YTD 2017 9
Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Hologic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 11
Asset Transactions 12
KV Pharma Acquires Rights To Makena From Hologic For US$199.5 Million 12
Acquisition 14
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 14
Hologic Inc – Key Competitors 16
Hologic Inc – Key Employees 17
Hologic Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Affiliate 20
Recent Developments 21
Financial Announcements 21
Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 21
Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 23
May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 25
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 26
Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 28
Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 30
Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 32
Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016 33
Corporate Communications 35
May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 35
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 36
Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 37
Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors 38
Legal and Regulatory 39
Jan 19, 2016: Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Hologic Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Hologic Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Hologic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Hologic Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Hologic Inc, Medical Devices Deals, 2011 to YTD 2017 9
Hologic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 11
KV Pharma Acquires Rights To Makena From Hologic For US$199.5 Million 12
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 14
Hologic Inc, Key Competitors 16
Hologic Inc, Key Employees 17
Hologic Inc, Other Locations 18
Hologic Inc, Subsidiaries 18
Hologic Inc, Affiliate 20

★海外企業調査レポート[Hologic Inc (HOLX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NovaDigm Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, vaccine clinical supplies, ALS3 vaccines, bacterial and fungal vaccine antigens, fungal a …
  • Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Abramson Cancer Center (Abramson) formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include …
  • UbiQ Bio BV-製薬・医療分野:企業M&A・提携分析
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …
  • Knoll, Inc.:企業の戦略・SWOT・財務情報
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Entasis Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Entasis Therapeutics Inc (Entasis) discovers and develops anti-infective products for drug-resistant bacterial infections. The company’s pipeline products include ETX2514, a potent inhibitor of class A, C, and D beta-lactamases intended to treat serious gram-negative infections, such as Acin …
  • Sodexo SA:企業の戦略・SWOT・財務情報
    Sodexo SA - Strategy, SWOT and Corporate Finance Report Summary Sodexo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Ezz Steel Company SAE:企業の戦略・SWOT・財務情報
    Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report Summary Ezz Steel Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • QEP Resources, Inc.:企業の戦略・SWOT・財務情報
    QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Studsvik AB (SVIK):企業の財務・戦略的SWOT分析
    Studsvik AB (SVIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Black River Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Black River Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Ellomay Capital Ltd (ELLO):企業の財務・戦略的SWOT分析
    Summary Ellomay Capital Ltd (Ellomay), formerly NUR Macroprinters Ltd, is an energy and infrastructure consulting company that provides renewable energy, oil and gas exploration, and clean energy solutions. The company offers renewable energy services such as installation of photovoltaic plants, man …
  • TSI Holdings Co Ltd:企業の戦略・SWOT・財務分析
    TSI Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TSI Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Equinor ASA (EQNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). The company also has operations in several of the important oil and gas provinces in the …
  • Rotork Plc (ROR):石油・ガス:M&Aディール及び事業提携情報
    Summary Rotork Plc (Rotork) is a manufacturer of actuator. The company’s key offerings include electric actuators, fluid power actuators, gearboxes, mounting kits and precision control instruments. The company also provides installation, maintenance and repair, field services, technical support and …
  • Xerium Technologies Inc:企業の戦略的SWOT分析
    Xerium Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Ws Atkins Ltd
    Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Crescendo Biologics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company s pipeline includes humabody programs targeting oncology. It specializes in the antibody discoveries and development that include CAT, …
  • The Law Debenture Corp plc (LWDB):企業の財務・戦略的SWOT分析
    Summary The Law Debenture Corp plc (LDC) is a financial service provider that offers investment trust and independent fiduciary services. The company’s services include corporate trusts, pension trusteeship, whistle blowing services and governance services. It offers financial services such as trust …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆